About Pharmaceutics International
Pharmaceutics International is a Healthcare company based in Hunt Valley (United States) founded in 1994, and was acquired by Jabil in February 2025. Pharmaceutical dosage forms are manufactured by this CDMO. Pharmaceutics International offers products and services including Contract Analytical Services, Formulation Development Services, Aseptic Manufacturing, and Oral Manufacturing. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its legal entity is PHARMACEUTICS INTERNATIONAL, INC. Its competitors include Asymchem, Continuus Pharma and Aptuit; 2 of its 3 listed competitors have raised funding.
Company details
Pharmaceutics International was founded in 1994 and is located in Hunt Valley, United States. Operations are conducted as a contract development and manufacturing organization (CDMO) within the pharmaceutical sector. Services are centered on the production of various dosage forms, including solids, liquids, and semi-solids. Support is provided to clients for formulation development, scale-up, and commercial manufacturing, with a focus on regulatory compliance and quality standards.
- Headquarters Hunt Valley, United States
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website pharm-int.com
- Social LinkedIn X YouTube
- Acquired by Jabil (Feb 2025)
- Legal Name Pharmaceutics International, Inc
Products & Services of Pharmaceutics International
Pharmaceutics International offers a comprehensive portfolio of products and services, including Contract Analytical Services, Formulation Development Services, Aseptic Manufacturing, and Oral Manufacturing.
Provides reliable testing for drug quality and compliance.
Develops stable formulations for various pharmaceutical products.
Handles aseptic fill-finish for injectable drug manufacturing.
Produces tablets, capsules, and liquids for oral medications.
Apps and channels of Pharmaceutics International
its YouTube channel Pii, a Jabil Company has 97 subscribers and 10 videos.
Videos from Pharmaceutics International
The most watched videos on Pharmaceutics International's YouTube channel, Pii, a Jabil Company (97 subscribers). Click a video to play it here.
More on Pii, a Jabil Company.
Funding Insights of Pharmaceutics International
- Total Rounds 12
- Last Round Unspecified β $11.25M
- First Round $108M
(Sep 2016)
- Investors Count 4
Latest 10 of 12 funding rounds of Pharmaceutics International with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2024 | $11.25M | Unspecified | β | β | β |
| Jun 2023 | $6M | Unspecified | β | β | β |
| Dec 2022 | $3M | Unspecified | β | β | β |
| Oct 2022 | $9.01M | Unspecified | β | β | β |
| Aug 2022 | $5M | Unspecified | β | β | β |
| Jun 2022 | $5M | Unspecified | β | β | β |
| May 2022 | $5M | Debt – Conventional | β | β | β |
| Jan 2022 | $5M | Unspecified | β | β | β |
| May 2021 | $3M | Unspecified | β | β | β |
| Oct 2018 | $5.97M | Unspecified | β | β | β |
5 investors in total: 5 institutional.
Investors in Pharmaceutics International
Pharmaceutics International has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Jabil, PharmaScience and Signet Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
PE firm investing in North America and Europe | signethealthcarepartners.com | New York, United States | ||
Global private equity investments are managed by the firm. | athyrium.com | New York, United States | ||
Hildred is focused on private equity investments in healthcare. | hildredcapital.com | New York, United States | ||
Generic, branded, and over-the-counter pharmaceuticals are manufactured for global markets. | 1983 | pharmascience.com | Montreal, Canada | |
Manufacturing solutions, design capabilities, and supply chain services are provided. | 1966 | jabil.com | St. Petersburg, United States |
Investor details for Pharmaceutics International
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Pharmaceutics International
29 people are tracked at Pharmaceutics International (20 in leadership, 1 in board & advisors, 8 in team).
| Name | Role | Group |
|---|---|---|
Travis Webb | Chief Science Officer | Leadership |
John Fowler | President & CEO | Leadership |
Cathy S. Sioma | Director Analytical QC | Leadership |
Greg Sutton | Head Of Engineering | Leadership |
Khurshaid Kazmi | Vice President Operations | Leadership |
Tom Pamukcoglu | VP, Quality | Leadership |
Irina Prudnikova | Associate Director, Analytical Research & Development, R&D | Leadership |
Joel Montes | Sr. Director, Quality Management Systems And Compliance | Leadership |
Joseph M. Kiely | Chief Financial Officer | Leadership |
Michael Curry | VP, Aseptic Operations | Leadership |
Samuel Chia | Director, Aseptic Operations & Plant Manager | Leadership |
Chanda Mimaros | Director Of Aseptic Manufacturing QA | Leadership |
Koshy George | Associate Director of the Manufacturing, Science & Technology | Leadership |
Alex Borodin | Senior Director, Supply Chain | Leadership |
Mehul Soni | Director Of Microbiology | Leadership |
Jason Savage | Vice President Human Resources | Leadership |
Dylan Amig | Head of Manufacturing & Packaging | Leadership |
Bryan Braxton | Senior Director, Aseptic R&D | Leadership |
Sundeep Sethia | Head, R&D | Leadership |
Devan Patel | VP. Client Services | Leadership |
9 more people are available in the full profile.
Complete people profiles for Pharmaceutics International
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Pharmaceutics International
4 dated milestones of Pharmaceutics International across 31 years, from founding to its latest funding, stage changes and deals.
- Founded Pharmaceutics International is founded.
- Funding First funding round of $108.0M.
- Funding Latest funding round, Unspecified, of $11.2M.
- Exit Acquired by Jabil.
Competitors of Pharmaceutics International
Pharmaceutics International has 3 listed competitors in our database, 2 of them funded. They include Asymchem, Continuus Pharma and Aptuit.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| asymchem.com | 1995 | Morrisville, United States | 48 | APIs and peptides are developed and manufactured by Asymchem. | ||
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | |
| aptuit.com | 2004 | Greenwich, United States | $14.23M | Contract research and development services for small molecules are offered. |
Detailed competitors of Pharmaceutics International
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Pharmaceutics International
The website of Pharmaceutics International (pharm-int.com) receives about 6.3K visits a month and ranks #2,825,984 among all websites worldwide, #3,790 in Biotechnology and Pharmaceuticals.
- Monthly visits6.3K
▼ 24% vs previous month
- Unique visitors3.5K
per month
- Global rank#2,825,984
among all websites
- Category rank#3,790
Health · Biotechnology and Pharmaceuticals
- Bounce rate58%
- Pages per visit1.4
- Average visit14 sec
- DevicesDesktop 28% Β· Mobile 72%
Websites whose visitors overlap most with Pharmaceutics International. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
alcami.com | alcami.com | 100% | #1,625,392 | β | |
| curiaglobal.com | 100% | 29.7K | #736,785 | View details | |
| patheon.com | 97% | 89.1K | #488,648 | View details | |
| argonautms.com | 96% | 9.6K | #2,712,987 | View details | |
| recipharm.com | 94% | 21.8K | #1,103,989 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 17 similar websites and full traffic analytics for Pharmaceutics International
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Pharmaceutics International (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pharmaceutics International
Complete news archive for Pharmaceutics International
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmaceutics International
Pharmaceutics International was founded in 1994 and raised its 1st funding round 22 years after it was founded.
Pharmaceutics International is headquartered in Hunt Valley, United States. It is registered at Hunt Valley, Maryland, United States.
Pharmaceutics International was founded in 1994 and is located in Hunt Valley, United States. Operations are conducted as a contract development and manufacturing organization (CDMO) within the pharmaceutical sector. Services are centered on the production of various dosage forms, including solids, liquids, and semi-solids. Support is provided to clients for formulation development, scale-up, and commercial manufacturing, with a focus on regulatory compliance and quality standards.
Pharmaceutics International's top competitors include Asymchem, Aptuit and Continuus Pharma.
Pharmaceutics International offers Contract Analytical Services, Formulation Development Services, Aseptic Manufacturing, and Oral Manufacturing.
Pharmaceutics International has 5 investors. Key investors include Jabil, PharmaScience, Signet Healthcare Partners, Athyrium Capital Management, and Hildred.
Pharmaceutics International operates through Pharmaceutics International, Inc.
Yes. Pharmaceutics International was acquired by Jabil in February 2025.

